Safinamide mesylate, Brodalumab, Guselkumab, and Abaloparatide

J Am Pharm Assoc (2003). 2018 Jan-Feb;58(1):123-127. doi: 10.1016/j.japh.2017.12.005.
No abstract available

MeSH terms

  • Alanine / adverse effects
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Benzylamines / adverse effects
  • Benzylamines / therapeutic use*
  • Humans
  • Mesylates / adverse effects
  • Mesylates / therapeutic use*
  • Parathyroid Hormone-Related Protein / adverse effects
  • Parathyroid Hormone-Related Protein / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Benzylamines
  • Mesylates
  • Parathyroid Hormone-Related Protein
  • guselkumab
  • brodalumab
  • safinamide
  • abaloparatide
  • Alanine